Cathie Wood’s ARK Invest Sells Over 125,000 Shares of Iovance Bio

One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.

Check out all of the ARK Invest sales for Wednesday:

FundTickerNameShares
ARKF3690HKMEITUAN1,342,426
ARKF9923HKYEAHKA339,600
ARKF6060HKZHONGAN ONLINE P&C INSURANCE1,339,400
ARKGSEERSEER152,557
ARKGRHHBYROCHE66,000
ARKGPSTIPLURISTEM THERAPEUTICS16,223
ARKGBMYBRISTOL-MYERS SQUIBB114,400
ARKKIOVAIOVANCE BIOTHERAPEUTICS128,163
ARKKNTDOYNINTENDO53,300
ARKQXONEEXONE82,333
ARKWLCLENDINGCLUB164,932
ARKWNFLXNETFLIX192

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: Goldman Sachs Says Buy These 4 Top Oil Stocks With Huge 2022 Upside Potential


Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Source: Read Full Article